ArticleJournal of market access & health policy2024

Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease.

Michal Pochopien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.